PCM
LMRI

Prelude Capital Management’s Lumexa Imaging Holdings LMRI Stock Holding History

Prelude Capital Management’s Portfolio LMRI Stock Details LMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-299,491
Closed -$2.58M – 1617
2026
Q1 		$2.58M Buy
+299,491
New +$4.11M 0.2% 124

Other funds holding LMRI

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TI
Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Prelude Capital Management's LMRI Position: Q2 2026 in Review

Prelude Capital Management sold out of Lumexa Imaging Holdings (LMRI) in Q2 2026, closing a stake of 299,491 shares — an estimated $2.58M sold.

Prelude Capital Management first reported a position in LMRI in Q1 2026 and held it in 1 quarter. The position peaked at $2.58M in Q1 2026. 102 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

  • Prelude Capital Management reported no remaining Lumexa Imaging Holdings position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 299,491 Lumexa Imaging Holdings shares in Q2 2026, an estimated $2.58M.
  • Prelude Capital Management first reported a position in Lumexa Imaging Holdings in Q1 2026 and held it in 1 quarter.
  • Prelude Capital Management's Lumexa Imaging Holdings position peaked at $2.58M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.